Antibody Industry Is Gigantic to Grow at a High CAGR 5.3% over the Forecast Period 2019 and 2025: QYResearch
QYResearch is a leading market research publisher which pursuits high product quality with the belief that quality is the soul of business and consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience.
Los Angeles, CA -- (SBWire) -- 02/02/2019 --Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called "antigens"). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
The global Antibody market is valued at 7330 million US$ in 2018 is expected to reach 10500 million US$ by the end of 2025, growing at a CAGR of 5.3% during 2019-2025.
In Vitro Diagnostics (IVD) are tests used to detect disease, infections and other medical conditions. The growing need of IVD testing arises due to increasing incidences of chronic and infectious diseases and growing geriatric population prone to immunological disorders. Moreover, increased application of personalized medicines and widespread knowledge of rare diseases are boosting the growth of IVD market. In the recent years, antibody used for IVD industry developed rapidly in China
There is a gap between China antibody manufacturers and Europe/America. In China, about 26% of consumption antibody import from foreign manufactures, such as Hytest, Roche, Thermo Fisher. There are also some local producers, such as Fapon, Genscript, Kitgen, Leadman, MACCURA, Wondfo, etc. Fapon is the leading player in China.
In classification, antibody can be divided into polyclonal antibody and monoclonal antibody. Monoclonal antibody hold the mostly share the China share about 91.12%
In application, antibody downstream is wide and recently antibody has impacted by the hospital, medical research institutions, etc. Hospital holds about 91.21% of whole China antibody consumption in 2016.
Access PDF Version of this Report @ https://www.qyresearch.com/sample-form/form/949683/global-antibody-forecast-amp%3B-opportunities
The manufacture region is concentrated in Central China, East China and Southwest China, of which East China is the largest region with the share 33.20% in 2016. The sales shares of Southwest China and Central China were 15.12% and 14.56%.
This report focuses on Antibody volume and value at global level, regional level and company level. From a global perspective, this report represents overall Antibody market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Roche
Johnson & Johnson
Merck
Novartis
AbbVie
Amgen
Pfizer
Bayer
Lilly
Bristol-Myers Squibb
GlaxoSmithKline
Biogen
AstraZeneca
Sanofi
Alexion Pharmaceuticals
Seattle Genetics
Segment by Regions
North America
Europe
China
Japan
Segment by Type
IgM
IgG
IgA
Other
Segment by Application
Therapeutic
Research
Diagnostic
Access Full Comprehensive Industry Insights @ https://www.qyresearch.com/settlement/pre/a9440ae884cb48c079cdc17e78547e2d,0,1,Global%20Antibody%20Forecast%20&%20Opportunities%202019
Benefits of Purchasing QY Research Report:
Analyst Support: Get you query resolved from our expert analysts before and after purchasing the report
Customer's Satisfaction: Our expert team will assist with all your research needs and customize the report
Inimitable Expertise: Analysts will provide deep insights about the reports
Assured Quality: We focus on the quality and accuracy of the report
About QYResearch
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.
Media Relations Contact
Rahul Singh
Director - Digital Marketing
QY Research, Inc.
1-626-295-2442
https://www.qyresearch.com/index/detail/949683/global-antibody-forecast-amp%3B-opportunities
View this press release online at: http://rwire.com/1137446